Combination Therapy For The Treatment Of Glioblastoma

Patent No. EP3038647 (titled "Combination Therapy For The Treatment Of Glioblastoma") was filed by F Hoffmann LA Roche on Aug 29, 2014. The application was issued on Mar 27, 2019.

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

Company	Opposition Date	Representative
AMGEN	Dec 23, 2019	DORRIES
AMGEN	Dec 23, 2019	DORRIES, HANS ULRICH , DF-MP DORRIES FRANK-MOLNIA & POHLMAN
NEUEFEIND	Dec 20, 2019	MAIWALD

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

Date
Description

Get instant alerts for new documents

Sep 21, 2020
Termination of the opposition proceedings with revocation of patent
Jul 14, 2020
Brief communication - Opposition proceedings
Jul 14, 2020
Brief communication - Opposition proceedings
Jul 14, 2020
Brief communication - Opposition proceedings
Jul 7, 2020
(Electronic) Receipt
Jul 7, 2020
Letter accompanying subsequently filed items
Jul 7, 2020
Withdrawal of an opposition
Jun 22, 2020
Advice of delivery
Jun 17, 2020
Advice of delivery
Jun 12, 2020
Advice of delivery
Jun 10, 2020
Acknowledgement of a document
Jun 10, 2020
Acknowledgement of a document
Jun 10, 2020
Acknowledgement of a document
Jun 10, 2020
Decision revoking the European patent
Jun 10, 2020
Decision revoking the European patent
Jun 10, 2020
Decision revoking the European patent
Jun 3, 2020
(Electronic) Receipt
Jun 3, 2020
Letter accompanying subsequently filed items
Jun 3, 2020
Request for revocation of patent
Jan 31, 2020
Communication of a notice of opposition and request to file observations
Jan 31, 2020
Notice of further oppositions to opponent(s)
Jan 31, 2020
Notice of further oppositions to opponent(s)
Jan 16, 2020
Communication of a notice of opposition - first information to patent proprietor
Jan 16, 2020
Communication of a notice of opposition - first information to patent proprietor
Jan 14, 2020
Consolidated list of cited opposition documents
Dec 23, 2019
(Electronic) Receipt
Dec 23, 2019
Any annexes (other than citation) to an opposition letter
Dec 23, 2019
Citation in opposition procedure - 017
Dec 23, 2019
Citation in opposition procedure - 018
Dec 23, 2019
Citation in opposition procedure - 019
Dec 23, 2019
Citation in opposition procedure - 020
Dec 23, 2019
Citation in opposition procedure - 021
Dec 23, 2019
Citation in opposition procedure - 022
Dec 23, 2019
Citation in opposition procedure - 023
Dec 23, 2019
Citation in opposition procedure - 024
Dec 23, 2019
Citation in opposition procedure - 025
Dec 23, 2019
Citation in opposition procedure - 026
Dec 23, 2019
Citation in opposition procedure - 027
Dec 23, 2019
Citation in opposition procedure - 028
Dec 23, 2019
Citation in opposition procedure - 029
Dec 23, 2019
Citation in opposition procedure - 030
Dec 23, 2019
Citation in opposition procedure - 031
Dec 23, 2019
Citation in opposition procedure - 031
Dec 23, 2019
Citation in opposition procedure - 032
Dec 23, 2019
Citation in opposition procedure - 033
Dec 23, 2019
Non-patent literature cited during the opposition procedure
Dec 23, 2019
Non-patent literature cited during the opposition procedure
Dec 23, 2019
Notice of opposition
Dec 23, 2019
Notice of opposition
Dec 20, 2019
(Electronic) Receipt
Dec 20, 2019
Citation in opposition procedure - 001
Dec 20, 2019
Citation in opposition procedure - 002
Dec 20, 2019
Citation in opposition procedure - 003
Dec 20, 2019
Citation in opposition procedure - 004
Dec 20, 2019
Citation in opposition procedure - 005
Dec 20, 2019
Citation in opposition procedure - 006
Dec 20, 2019
Citation in opposition procedure - 007
Dec 20, 2019
Citation in opposition procedure - 008
Dec 20, 2019
Citation in opposition procedure - 009
Dec 20, 2019
Citation in opposition procedure - 010
Dec 20, 2019
Citation in opposition procedure - 011
Dec 20, 2019
Citation in opposition procedure - 012
Dec 20, 2019
Citation in opposition procedure - 013
Dec 20, 2019
Citation in opposition procedure - 014
Dec 20, 2019
Non-patent literature cited during the opposition procedure
Dec 20, 2019
Non-patent literature cited during the opposition procedure
Dec 20, 2019
Notice of opposition
Dec 20, 2019
Notice of opposition
Apr 8, 2019
Transmission of the certificate for a European patent pursuant to Rule 74 EPC
Feb 28, 2019
Decision to grant a European patent
Feb 7, 2019
Brief communication to applicant/representative
Feb 4, 2019
(Electronic) Receipt
Feb 4, 2019
(Electronic) Receipt
Feb 4, 2019
Filing of the translations of the claims
Feb 4, 2019
French translation of claims
Feb 4, 2019
German translation of the claims
Feb 4, 2019
Letter accompanying subsequently filed items
Feb 4, 2019
Letter accompanying subsequently filed items
Feb 4, 2019
Letter concerning the designation and/or extension and/or validation of states
Oct 19, 2018
Bibliographic data of the European patent application
Oct 19, 2018
Communication about intention to grant a European patent
Oct 19, 2018
Intention to grant (signatures)
Oct 19, 2018
Text intended for grant (clean copy)
Oct 19, 2018
Text intended for grant (sequence listing)
Oct 19, 2018
Text intended for grant (version for approval)
Jun 13, 2018
(Electronic) Receipt
Jun 13, 2018
Amended claims with annotations
Jun 13, 2018
Amended description with annotations
Jun 13, 2018
Claims
Jun 13, 2018
Description
Jun 13, 2018
Grant of extension of time limit (examination procedure)
Jun 13, 2018
Letter accompanying subsequently filed items
Jun 13, 2018
Reply to communication from the Examining Division
Jun 7, 2018
(Electronic) Receipt
Jun 7, 2018
Letter accompanying subsequently filed items
Jun 7, 2018
Request for extension of time limit to communication from the Examining Division
Feb 7, 2018
Annex to the communication
Feb 7, 2018
Communication from the Examining Division
Feb 1, 2018
Examination started
Sep 26, 2017
(Electronic) Receipt
Sep 26, 2017
Amended claims filed after receipt of (European) search report
Sep 26, 2017
Amended claims with annotations
Sep 26, 2017
Amendments received before examination
Sep 26, 2017
Letter accompanying subsequently filed items
Mar 31, 2017
Invitation to declare maintenance of the application and to correct deficiencies in the Written Opinion/amend application
Mar 14, 2017
Communication regarding the transmission of the European search report
Mar 14, 2017
European search opinion
Mar 14, 2017
Information on Search Strategy
Mar 14, 2017
Supplementary European search report
Jun 8, 2016
Notification on forthcoming publication of bibliographic data
May 25, 2016
Invitation to indicate correct address of inventor
May 17, 2016
Invitation to indicate correct address of inventor
May 17, 2016
Invitation to indicate correct address of inventor
May 12, 2016
Letter which had not been notified
May 9, 2016
Letter which had not been notified
May 3, 2016
Letter which had not been notified
Apr 14, 2016
Communication regarding possible amendment of the application/payment of claims fee
Apr 11, 2016
Communication to designated inventor
Apr 11, 2016
Communication to designated inventor
Apr 11, 2016
Communication to designated inventor
Apr 11, 2016
Communication to designated inventor
Mar 15, 2016
Copy of the international preliminary report on patentability
Feb 4, 2016
(Electronic) Receipt
Feb 4, 2016
Request for entry into the European phase
Jan 11, 2016
Information on entry into European phase
Mar 23, 2015
Priority document (electronically transmitted)
Mar 23, 2015
Priority document (electronically transmitted)
Mar 5, 2015
Converted Sequence Listing
Mar 5, 2015
Copy of the international search report
Mar 5, 2015
Published international application - A1

EP3038647

F HOFFMANN LA ROCHE

Application Number: EP14840968A
Filing Date: Aug 29, 2014
Status: Revoked; Sep 25, 2020
Publication Date: Mar 27, 2019
External Links: Slate, Register , Google Patents

IP Verse

Combination Therapy For The Treatment Of Glioblastoma

Patent Summary

Patent Family

Patent Oppositions (3)

Dossier Documents

EP3038647